 - Use of any investigational or non-registered product drug or vaccine other than the study vaccines or planned administration administration of vaccine not foreseen by the study protocol within 30 days preceding the first dose of study vaccine during study period, or planned use during study period with exception of oral polio vaccine OPV. 